Who is sponsoring NCT02691442?

NCT02691442 is sponsored by University Hospital, Antwerp.

What condition does NCT02691442 study?

NCT02691442 studies Other Peripheral Nerve Disease.

What drugs are being tested in NCT02691442?

Interventions: Ropivacaine 0.75%, Levobupivacaine 0.5%, Levobupivacaine 0.5% + epinephrin 1/200000.

What is the status of NCT02691442?

NCT02691442 is currently COMPLETED.

Last reviewed 2016-08-11 · How we verify

Comparison of the Analgesic Effect of the Local Anesthetics Ropicacaine, Levobupivacaine, and Levobupivacaine + Epinephrin Via Interscalene Nerve Block in Patients Undergoing Shoulder Arthroscopy Under General Anesthesia

NCT02691442 Phase 4 COMPLETED

Several reports have compared the duration of action of levobupivacaine and ropivacaine as local anesthetic. The most widely used method for sensory function evaluation is though means of a pinprick test. The investigators want to use the novel method of Quantitative Sensory Testing to better evaluate the anesthetic activity. This method used hot and cold sensation to assess small nerve fiber function. The investigators will assess the duration of action of different drugs when used in an inter scalene nerve block in patients scheduled for shoulder surgery.

Details

Lead sponsor	University Hospital, Antwerp
Phase	Phase 4
Status	COMPLETED
Enrolment	30
Start date	2010-12
Completion	2016-04

Conditions

Other Peripheral Nerve Disease

Interventions

Ropivacaine 0.75%
Levobupivacaine 0.5%
Levobupivacaine 0.5% + epinephrin 1/200000

Primary outcomes

Length of nerve block measured in longitudinally recorded significant changes in sensory thresholds using quantitative sensory testing — 24 hours after intervention
Length of difference in cold and heat pain and sensation measured with quantitative sensory testing